Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Victoria Insurance Tbk. (VINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Victoria Insurance Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Victoria Insurance Tbk. trades at Rp139 (market cap 215.93B, 243K 24h volume). The key difference: Victoria Insurance Tbk. is the larger of the two by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 243K). Which is the better fit depends on your goals.
| OBAT | VINS | |
|---|---|---|
Market Cap | 172.82B | 215.93B |
Volume | 592.2K | 243K |
Lot | 5.92K | 2.43K |
Turnover | 147.05M | 33.63M |
Average Price | 248.31 | 138.4 |
Value | 147.05M | 33.63M |
Indicative Equilibrium Price | 254 | 139 |
Indicative Equilibrium Volume | 10 | 5.2K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Victoria Insurance Tbk.
PT Victoria Insurance Tbk (the Company) has been established since 1978 under the name Great PT. Asuransi Agung Asia. In November 1989, changed its name to PT. Asuransi Summa and changed back in July 1993 under the name General PT Asuransi Centris and as of August 2010, all shares and the Companys management was taken over by a large company group under the banner of Victoria and the Company name was changed to PT Victoria Insurance. Victoria Group is a national investment holding company with portfolio business including financial services, banking, chemicals, steel, agricultural, plantations.
Read more on VINS →
